In June 2026, Alkermes plc reported detailed positive phase 2 Vibrance‑2 results for its oral orexin 2 receptor agonist ...
CMiC, the leading AI-powered construction ERP, has released a new report in collaboration with Nucleus Research: Driving Cost Control and Operational Visibility ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results